Brief: RhoVac Receives Approval In Germany And Belgium To Start Clinical Phase IIb Study In Prostate Cancer

Chosa Oncology AB

10/01/2020 12:15

Jan 10 (Reuters) - RhoVac AB  RHOVAC.TE :
    * RHOVAC RECEIVES APPROVAL IN GERMANY AND BELGIUM TO START
CLINICAL PHASE IIB STUDY IN PROSTATE CANCER
    * RHOVAC AB - RESULTS REPORTING ON PRIMARY OBJECTIVE OF
STUDY IS
EXPECTED DURING H2 2021.
    * RHOVAC AB - AMBITION IS FOR ALL PATIENTS TO BE RECRUITED
BY END
Q3 2020

Source text for Eikon:  ID:nWkr51xz9Q 
Further company coverage:  RHOVAC.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))